These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7016654)

  • 1. [Dilazep].
    Pirani R; Gruppillo P
    G Ital Cardiol; 1980; 10(10):1419-25. PubMed ID: 7016654
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results of the clinical testing of a new coronary drug, Cormelian].
    Pollter J
    Fortschr Med; 1972 Apr; 90(10):399-404. PubMed ID: 4616888
    [No Abstract]   [Full Text] [Related]  

  • 3. [Polygraphic and electrocardiographic study of a new coronary therapeutic agent: dilazep].
    Parenti B; Selvaggi R
    Clin Ter; 1980 Jan; 92(2):155-63. PubMed ID: 7389275
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antiplatelet therapy and platelet function studies in elderly patients with ischemic heart disease--evaluation of whole blood platelet aggregation].
    Kawamura H; Kodama H; Takeuchi G; Kohsaka K; Suzuki S; Nitta M; Takada K; Mitomo Y; Yamamoto M
    Rinsho Ketsueki; 1986 Oct; 27(10):1815-22. PubMed ID: 3820607
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of dilazep on platelet thrombus formation and intimal thickening after mechanical injury of aorta in rabbit].
    Hayashi T
    Fukuoka Igaku Zasshi; 1988 Oct; 79(10):723-37. PubMed ID: 3248764
    [No Abstract]   [Full Text] [Related]  

  • 6. [Polycentric and hemodynamic experimentation with a new coronary active drug: dilazep].
    Baldrighi V; Barbaresi F; Plancher AC; Portioli I
    Clin Ter; 1976 Aug; 78(4):303-62. PubMed ID: 795597
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cardiodynamic changes induced with dilazep in chronic coronary insufficiency].
    Fogari R
    G Ital Cardiol; 1980; 10(12):1675-8. PubMed ID: 7250592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of myocardial reactive hyperemia and adenosine-induced coronary vasodilation by dilazep, a new adenosine potentiator.
    Saito D; Kusachi S; Nagashima H; Haraoka S
    Arzneimittelforschung; 1982; 32(9):1029-32. PubMed ID: 6890820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Noninvasive quantitative evaluation of cardiac reverse--effects of dilazep (adenosine like agent)].
    Morishita T; Arai C; Abe N; Takeuchi K; Hasegawa M; Takayama Y; Emori I; Yoshinori K
    Kokyu To Junkan; 1988 Jun; 36(6):675-9. PubMed ID: 3217607
    [No Abstract]   [Full Text] [Related]  

  • 10. Dilazep-induced reduction of ischemic necrosis in rats with coronary artery occlusion.
    Chiariello M; Brevetti G; Genovese A; Cataffo A; Ambrosio G; Condorelli M
    Int J Cardiol; 1983; 2(3-4):339-48. PubMed ID: 6840902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of dilazep in the treatment of coronary insufficiency. A randomized and double-blind study on subjects with stable, exertion angina].
    Romano M; De Caprio L; Scarafile P; Carlomagno A; Meccariello P; Condorelli M
    Minerva Cardioangiol; 1980; 28(7-8):489-94. PubMed ID: 7005711
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of coronary heart disease using Cormelian-Digotab. First communication on a field experiment of 107 residential physicians].
    Pollter J; Schnitker J
    Med Welt; 1975 Oct; 26(44):2007-12. PubMed ID: 1186488
    [No Abstract]   [Full Text] [Related]  

  • 13. [Efficiency of Cormelian in coronary insufficiency. Results of a double-blind study].
    Gillner H; Pollter J; Schnitker J; Sievers HG; Zylmann G
    Med Monatsschr; 1975 Feb; 29(2):82-7. PubMed ID: 1092990
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular effects of a single high dose of dilazep by oral route.
    Ibba GV; Terrosu P; Franceschino V; Contini GM
    Int J Cardiol; 1986 Jun; 11(3):337-48. PubMed ID: 3721632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dilazep on hemoglobin-oxygen affinity in patients with ischemic heart disease.
    Koshu M; Sugimoto T; Terada Y; Uraoka T
    Jpn Heart J; 1985 Jul; 26(4):521-30. PubMed ID: 3903248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dilazep on regional myocardial blood flow during selective coronary hypotension.
    Fujii M; Kikuchi Y; Koyanagi S; Okamatsu S; Tomoike H; Nakamura M
    Arzneimittelforschung; 1981; 31(12):2067-71. PubMed ID: 7199300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cormelian (Dilazep) a new coronary active substance].
    Reuter H
    Z Allgemeinmed; 1974 Oct; 50(28):1255-6. PubMed ID: 4614598
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effect of dilazep on circulating platelet aggregation in diabetics].
    Carleo R; Buda GR; Cerciello A; Dell'Aversano R; Monaco GP; Trovato C; Vigilante M
    Boll Soc Ital Biol Sper; 1983 Dec; 59(12):1832-7. PubMed ID: 6671042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human platelet aggregation tests in vitro. Effects of dilazep.
    Ponari O; Manotti C
    Arzneimittelforschung; 1981; 31(1):97-101. PubMed ID: 7194099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amelioration of albuminuria induced by dilazep administration in aminonucleoside nephrosis of rats.
    Nagase M; Kobayashi S; Sakakibara K; Honda N
    Nihon Jinzo Gakkai Shi; 1985 Mar; 27(3):385-91. PubMed ID: 4021200
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.